Not applicableStudy completedNCT02921828
What this trial is testing
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Who this might be right for
Multiple Myeloma
Celgene 1,149